CC
Publicaties op Oncologisch.com
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Rela...
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, an...
Belantamab mafodotin plus bortezomib and dexamethasone in patiënten met relapsed or refractory multiple myeloma (DREA...
Belantamab mafodotin plus bortezomib-dexamethason bij myeloom: DREAMM-7 fase III